E24: NMDA Receptor Antagonists: Ketamine, Esketamine (Spravato), and Dextromethorphan+Bupropion (Auvelity)

episode

This Is Your Brain On Drugs Psychiatry Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Donald Is Done For; All Hell Breaks Loose After Devastating Attacks 29 min · 24 Sep 2026 · IHIP News

Michael Petrillo | Melbourne City Director of Football (24.09.26) 4 min · 24 Sep 2026 · Whateley

"Saving Super Rugby" 1h 12m · 24 Sep 2026 · The Agenda

316. Why the world’s economic glue is becoming unstuck 45 min · 24 Sep 2026 · The Rest Is Money

Fletch, Vaughan & Hayley's Lil Bitta Pod - 24th September 2026 4 min · 24 Sep 2026 · ZM's Fletch, Vaughan & Hayley

Grand Final: Fremantle vs. Brisbane preview | Strategy 2026 with Brenton Sanderson (24.09.26) 22 min · 24 Sep 2026 · Whateley

Report any issue

Source

Recorded30 Jan 2025

Publisherfeeds.podcastle.ai

Handlerec:12104180

Show notes

Today we have an interesting episode. We are covering the first of a very new class of antidepressants, the NMDA receptor antagonists. These are the first antidepressants approved for use for depression which do not interact with the monoamine system, and many more may be coming out in the future. We will talk about ketamine, its sister, esketamine, and the only oral form, a combination of the cough suppressant dextromethorphan and bupropion. Find out how this new class of antidepressant works for depression and what my opinion is of these new medications!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in